Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) EPS (Basic): 2017-2025

Historic EPS (Basic) for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to -$0.97.

  • Dianthus Therapeutics' EPS (Basic) fell 31.08% to -$0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.49, marking a year-over-year decrease of 148.74%. This contributed to the annual value of -$2.55 for FY2024, which is 69.82% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported EPS (Basic) of -$0.97 as of Q3 2025, which was down 10.23% from -$0.88 recorded in Q2 2025.
  • Dianthus Therapeutics' 5-year EPS (Basic) high stood at $8.95 for Q4 2023, and its period low was -$12.73 during Q2 2023.
  • For the 3-year period, Dianthus Therapeutics' EPS (Basic) averaged around -$1.90, with its median value being -$0.82 (2025).
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 177.36% in 2023, then crashed by 109.16% in 2024.
  • Over the past 4 years, Dianthus Therapeutics' EPS (Basic) (Quarterly) stood at -$11.57 in 2022, then surged by 177.36% to $8.95 in 2023, then tumbled by 109.16% to -$0.82 in 2024, then crashed by 31.08% to -$0.97 in 2025.
  • Its last three reported values are -$0.97 in Q3 2025, -$0.88 for Q2 2025, and -$0.82 during Q1 2025.